NM_024675.4(PALB2):c.2846G>A (p.Cys949Tyr) AND Hereditary cancer-predisposing syndrome
- Germline classification:
- Conflicting interpretations of pathogenicity (2 submissions)
- Last evaluated:
- Jan 30, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001804846.5
Allele description [Variation Report for NM_024675.4(PALB2):c.2846G>A (p.Cys949Tyr)]
NM_024675.4(PALB2):c.2846G>A (p.Cys949Tyr)
Condition(s)
- Name:
- Hereditary cancer-predisposing syndrome
- Synonyms:
- Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672
-
hypothetical protein 3927AP2_19 [Mannheimia phage vB_MhM_3927AP2]
hypothetical protein 3927AP2_19 [Mannheimia phage vB_MhM_3927AP2]gi|738492452|gb|AJA73175.1|Protein
-
secretion activator protein, hypothetical [Brucella abortus bv. 1 str. 9-941]
secretion activator protein, hypothetical [Brucella abortus bv. 1 str. 9-941]gi|62196041|gnl|nadcusda|BruAb1_099 AAX74341.1|Protein
-
Mus musculus guanine nucleotide binding protein nucleolar 2 (Gnl2), mRNA
Mus musculus guanine nucleotide binding protein nucleolar 2 (Gnl2), mRNAgi|240120092|ref|NM_145552.2|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024